New Risk • Mar 31
New major risk - Revenue and earnings growth Earnings have declined by 45% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Mar 25
Full year 2025 earnings released Full year 2025 results: Revenue: €207.4m (flat on FY 2024). Net loss: €21.2m (loss widened 13% from FY 2024). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 6.4% growth forecast for the Machinery industry in Italy. Reported Earnings • Sep 16
First half 2025 earnings released: €0.18 loss per share (vs €0.31 loss in 1H 2024) First half 2025 results: €0.18 loss per share (improved from €0.31 loss in 1H 2024). Revenue: €90.4m (up 4.0% from 1H 2024). Net loss: €13.0m (loss narrowed 41% from 1H 2024). Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Price Target Changed • Sep 12
Price target increased by 10% to €5.30 Up from €4.80, the current price target is an average from 2 analysts. New target price is 5.6% above last closing price of €5.02. Stock is up 66% over the past year. The company is forecast to post earnings per share of €0.036 next year compared to a net loss per share of €0.27 last year. Price Target Changed • Jul 14
Price target increased by 10% to €4.80 Up from €4.35, the current price target is an average from 2 analysts. New target price is 8.5% above last closing price of €4.43. Stock is up 32% over the past year. The company is forecast to post earnings per share of €0.031 next year compared to a net loss per share of €0.27 last year. Reported Earnings • Apr 16
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: €0.27 loss per share (improved from €1.44 loss in FY 2023). Revenue: €211.6m (flat on FY 2023). Net loss: €18.8m (loss narrowed 81% from FY 2023). Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 121%. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance. New Risk • Apr 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company. Major Estimate Revision • Sep 19
Consensus EPS estimates fall by 35% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €227.0m to €221.1m. Losses expected to increase from €0.11 per share to €0.14. Machinery industry in Italy expected to see average net income growth of 6.4% next year. Consensus price target of €4.00 unchanged from last update. Share price fell 3.7% to €3.03 over the past week. Reported Earnings • Jun 24
Full year 2023 earnings released: €1.44 loss per share (vs €0.024 profit in FY 2022) Full year 2023 results: €1.44 loss per share (down from €0.024 profit in FY 2022). Revenue: €212.2m (up 5.4% from FY 2022). Net loss: €99.6m (down €101.3m from profit in FY 2022). Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Major Estimate Revision • Jun 20
Consensus EPS estimates fall by 24% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €231.0m to €226.8m. Losses expected to increase from €0.10 per share to €0.13. Machinery industry in Italy expected to see average net income growth of 6.3% next year. Consensus price target up from €3.30 to €4.00. Share price fell 2.8% to €3.29 over the past week. Duyuru • Jun 05
Antares Vision S.p.A. to Report Q2, 2024 Results on Sep 12, 2024 Antares Vision S.p.A. announced that they will report Q2, 2024 results on Sep 12, 2024 Duyuru • Jun 01
Antares Vision S.p.A., Annual General Meeting, Jul 10, 2024 Antares Vision S.p.A., Annual General Meeting, Jul 10, 2024, at 10:00 W. Europe Standard Time. Location: via luigi illica n 5 20121, milano Italy Reported Earnings • May 29
Full year 2023 earnings released Full year 2023 results: Revenue: €217.3m (down 3.0% from FY 2022). Net loss: €99.9m (down €118.1m from profit in FY 2022). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Machinery industry in Italy. New Risk • May 14
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 8.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.6% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (3.7% net profit margin). Shareholders have been diluted in the past year (2.1% increase in shares outstanding). New Risk • Mar 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10.0% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Profit margins are more than 30% lower than last year (3.7% net profit margin). Shareholders have been diluted in the past year (2.0% increase in shares outstanding). Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to €2.97, the stock trades at a trailing P/E ratio of 23.8x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 75% over the past three years. New Risk • Mar 18
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.7% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (3.7% net profit margin). Shareholders have been diluted in the past year (2.0% increase in shares outstanding). Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €2.10, the stock trades at a trailing P/E ratio of 16.5x. Average forward P/E is 9x in the Machinery industry in Italy. Total loss to shareholders of 81% over the past three years. Major Estimate Revision • Feb 01
Consensus revenue estimates fall by 11% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €245.8m to €219.6m. Forecast loss of -€0.231, down from profit of €0.065 per share profit previously. Machinery industry in Italy expected to see average net income growth of 0.6% next year. Consensus price target down from €4.55 to €2.55. Share price rose 2.7% to €1.85 over the past week. Valuation Update With 7 Day Price Move • Jan 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €1.36, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Machinery industry in Italy. Total loss to shareholders of 87% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €0.99 per share. Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment deteriorates as stock falls 43% After last week's 43% share price decline to €1.67, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 9x in the Machinery industry in Italy. Total loss to shareholders of 83% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €1.05 per share. Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €2.94, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 9x in the Machinery industry in Italy. Total loss to shareholders of 71% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €1.18 per share. Valuation Update With 7 Day Price Move • Nov 08
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €3.00, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 9x in the Machinery industry in Italy. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €1.20 per share. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €3.56, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 68% over the past three years. Reported Earnings • Sep 14
First half 2023 earnings released: €0.16 loss per share (vs €0.027 loss in 1H 2022) First half 2023 results: €0.16 loss per share (further deteriorated from €0.027 loss in 1H 2022). Revenue: €101.5m (up 19% from 1H 2022). Net loss: €11.3m (loss widened €9.41m from 1H 2022). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings. New Risk • Sep 13
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.6% Last year net profit margin: 7.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.4% average weekly change). Minor Risk Profit margins are more than 30% lower than last year (3.6% net profit margin). Valuation Update With 7 Day Price Move • Sep 12
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to €5.08, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Machinery industry in Italy. Total loss to shareholders of 55% over the past three years. Price Target Changed • Apr 28
Price target decreased by 12% to €8.30 Down from €9.47, the current price target is an average from 2 analysts. New target price is 25% above last closing price of €6.66. Stock is down 20% over the past year. The company is forecast to post earnings per share of €0.33 for next year compared to €0.26 last year. Price Target Changed • Apr 13
Price target decreased by 7.5% to €9.03 Down from €9.77, the current price target is an average from 3 analysts. New target price is 49% above last closing price of €6.05. Stock is down 33% over the past year. The company is forecast to post earnings per share of €0.56 for next year compared to €0.26 last year. Reported Earnings • Mar 24
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: €0.26 (up from €0.19 in FY 2021). Revenue: €225.3m (up 26% from FY 2021). Net income: €18.2m (up 47% from FY 2021). Profit margin: 8.1% (up from 6.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 39%. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Major Estimate Revision • Mar 01
Consensus EPS estimates fall by 12% The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from €0.336 to €0.295. Revenue forecast unchanged from €224.9m at last update. Net income forecast to grow 93% next year vs 9.5% growth forecast for Machinery industry in Italy. Consensus price target down from €9.77 to €9.47. Share price was steady at €7.70 over the past week. Price Target Changed • Feb 28
Price target decreased by 7.2% to €9.47 Down from €10.20, the current price target is an average from 3 analysts. New target price is 22% above last closing price of €7.77. Stock is down 12% over the past year. The company is forecast to post earnings per share of €0.34 for next year compared to €0.19 last year. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Chairman of the Supervisory Board Francesco Menini was the last director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 18% share price gain to €8.32, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €5.41 per share. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €7.55, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 10x in the Machinery industry in Italy. Total loss to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €5.82 per share. Major Estimate Revision • Sep 15
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €219.0m to €224.3m. EPS estimate fell from €0.45 to €0.33 per share. Net income forecast to grow 122% next year vs 20% growth forecast for Machinery industry in Italy. Consensus price target down from €10.80 to €10.20. Share price fell 12% to €8.06 over the past week. Reported Earnings • Sep 09
First half 2022 earnings released: €0.03 loss per share (vs €0.044 loss in 1H 2021) First half 2022 results: €0.03 loss per share (improved from €0.044 loss in 1H 2021). Revenue: €86.3m (up 15% from 1H 2021). Net loss: €1.84m (loss narrowed 32% from 1H 2021). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment improved over the past week After last week's 15% share price gain to €9.90, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 10x in the Machinery industry in Italy. Total loss to shareholders of 6.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.00 per share. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 18% share price gain to €10.28, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 30x in the Healthcare Services industry in Europe. Total loss to shareholders of 9.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.31 per share. Price Target Changed • Apr 27
Price target decreased to €12.33 Down from €14.03, the current price target is an average from 3 analysts. New target price is 45% above last closing price of €8.48. Stock is down 32% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €0.19 last year. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Chairman of the Supervisory Body Francesco Menini was the last director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 10
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: €0.19 (down from €0.31 in FY 2020). Revenue: €181.6m (up 50% from FY 2020). Net income: €12.4m (down 32% from FY 2020). Profit margin: 6.8% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 20%, compared to a 39% growth forecast for the industry in Italy. Valuation Update With 7 Day Price Move • Mar 09
Investor sentiment deteriorated over the past week After last week's 18% share price decline to €7.80, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 28x in the Healthcare Services industry in Europe. Total loss to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €13.06 per share. Price Target Changed • Mar 08
Price target decreased to €12.33 Down from €14.03, the current price target is an average from 3 analysts. New target price is 58% above last closing price of €7.80. Stock is down 31% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.31 last year. Buying Opportunity • Jan 28
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be €13.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.6% per annum over the last 3 years. Earnings per share has declined by 34% over the last year. Reported Earnings • Sep 15
First half 2021 earnings released: €0.044 loss per share (vs €0.08 profit in 1H 2020) The company reported a soft first half result with weaker earnings and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €75.2m (up 29% from 1H 2020). Net loss: €2.71m (down 158% from profit in 1H 2020). Duyuru • Mar 31
Antares Vision S.p.A. announced that it expects to receive €1.7 million in funding Antares Vision S.p.A. (BIT:AV) announced a private placement of 690,000 shares at an issue price of €2.463768 per share for gross proceeds of €1,700,000 on March 29, 2021. The transaction has been approved by the board of directors. Analyst Estimate Surprise Post Earnings • Mar 11
Revenue and earnings miss expectations Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 40%, compared to a 483% growth forecast for the Healthcare Services industry in Italy. Is New 90 Day High Low • Feb 15
New 90-day high: €10.80 The company is up 8.0% from its price of €10.00 on 17 November 2020. The Italian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 12% over the same period. Is New 90 Day High Low • Jan 19
New 90-day high: €10.35 The company is up 4.0% from its price of €10.00 on 21 October 2020. The Italian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 13% over the same period. Major Estimate Revision • Dec 29
Analysts update estimates The 2020 consensus revenue estimate was lowered from €128.0m to €123.2m. Earnings per share (EPS) increased from €0.21 to €0.34 for the same period. Net income is expected to grow by 43% next year compared to 24% growth forecast for the Healthcare Services industry in Italy. The consensus price target increased from €12.10 to €12.50. Share price stayed mostly flat at €9.44 over the past week. Price Target Changed • Dec 28
Price target raised to €12.50 Up from €11.40, the current price target is provided by 1 analyst. The new target price is 34% above the current share price of €9.36. As of last close, the stock is down 14% over the past year. Is New 90 Day High Low • Dec 28
New 90-day low: €9.36 The company is down 15% from its price of €11.00 on 29 September 2020. The Italian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 9.0% over the same period. Is New 90 Day High Low • Oct 13
New 90-day low: €10.30 The company is down 10.0% from its price of €11.40 on 15 July 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 6.0% over the same period. Reported Earnings • Sep 25
First half earnings released Over the last 12 months the company has reported total profits of €16.1m, down 29% from the prior year. Total revenue was €121.5m over the last 12 months, largely unchanged from the prior year. Reported Earnings • Sep 23
First half earnings released Over the last 12 months the company has reported total profits of €16.1m, down 31% from the prior year. Total revenue was €121.7m over the last 12 months, down 1.2% from the prior year.